Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05384899 · ClinicalTrials.gov registry record

Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol

A clinical trial, sponsored by University of Washington.

Completed
Registry status
90
Enrollment target

NCT05384899 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 90 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05384899 has completed, sponsored by University of Washington.

COMPLETED
Registry status
90 participants
Enrollment target

Study Summary

Since its inception, KPMP has developed sophisticated protocols for collection and analysis of human kidney tissue, and for collection of biofluids. Members of the consortium have wide-ranging expertise in conducting clinical studies, processing kidney tissue, advanced structural and molecular analysis and complex bioinformatics analysis, which will be used to leverage effectively as a group to better understand kidney disease. This joint protocol aims to synergize the COVID-19 study efforts of KPMP academic research centers, to collectively study COVID-19, including its renal presentation using kidney tissue and/or biofluids from patients suffering from COVID-19. This will increase the breadth and depth of data available to the public to expedite discoveries, identify therapeutics, and improve outcomes for patients with COVID-19. It will additionally bring the expertise of KPMP investigators to bear against this pandemic.

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2021-06-15
Est. Completion 2022-10-30

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT05384899

The ClinicalTrials.gov registry entry for NCT05384899 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05384899 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05384899 about?

NCT05384899 is a clinical study titled "Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol". Since its inception, KPMP has developed sophisticated protocols for collection and analysis of human kidney tissue, and for collection of biofluids. Members of the consortium have wide-ranging expertise in conducting clinical studies, processing kidney tissue, advanced structural and molecular analy...

What is the current status of trial NCT05384899?

This trial is currently completed. The enrollment target is 90 participants. The study started on 2021-06-15. Estimated completion is 2022-10-30.

Who is sponsoring clinical trial NCT05384899?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.